Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SRAD | ATMU |
|---|---|---|
| Price | $12.08 | $46.18 |
| Change today | ▲ 2.72% | ▲ 1.05% |
| Market cap | $3.77B | $3.77B |
| Return, 3 months | -23.8% | -9.0% |
| Return, year to date | -49.2% | -10.8% |
| Return, 1 year | -52.8% | +5.1% |
| P/E (TTM) | 215.7 | 17.7 |
| P/B | 4.3 | 8.3 |
| P/E percentile vs own 5y | – | 56th |
| Dividend yield | – | 0.48% |
| Revenue growth (YoY, latest qtr) | +18.9% | +5.7% |
| Net profit growth (YoY) | -107.2% | +11.7% |
| Gross margin | 51.4% | 28.2% |
| Operating margin | 7.1% | 15.0% |
| Net margin | -0.9% | 11.8% |
| Return on equity | – | – |
| Analyst target vs. price | +49.7% | +33.2% |
| Analyst buy share | 70% | 67% |
| RSI (14) | 44 | 52 |
| 30-day volatility | 51.8% | 27.0% |
| Max drawdown, 1 year | -61.6% | -33.6% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
